| Followers | 35 |
| Posts | 2799 |
| Boards Moderated | 0 |
| Alias Born | 10/28/2013 |
Wednesday, May 28, 2014 1:20:21 PM
"Koman says - I have no idea why choosing multiple tumor injections make any sense at all as the next step.
Perhaps different tumors, although in the same body, express different antigens, and injecting each would cover more possible antigen expressions."
Maybe so. But I would think that most of the time they would be the same animal.
Injecting more than one of them would likely generate a larger systemic response because it would generate more activated DC's and probably involve more lymph nodes.
In addition to the simple linear increase in the systemic response, cluing the body that there are mets might invoke a disproportionate increase in the systemic response as the hunt for mets gets very serious.
It's unknown territory. Testing such possibilities makes sense to me.
And if I were a patient, I would want them to inject every tumor, of course, if they could. But I do understand why they must first check to see if that is even necessary. Just hope that at some point, if the systemic response is not dramatic, that they do follow through with further injections. Even if that had to be at a low dose.
Perhaps different tumors, although in the same body, express different antigens, and injecting each would cover more possible antigen expressions."
Maybe so. But I would think that most of the time they would be the same animal.
Injecting more than one of them would likely generate a larger systemic response because it would generate more activated DC's and probably involve more lymph nodes.
In addition to the simple linear increase in the systemic response, cluing the body that there are mets might invoke a disproportionate increase in the systemic response as the hunt for mets gets very serious.
It's unknown territory. Testing such possibilities makes sense to me.
And if I were a patient, I would want them to inject every tumor, of course, if they could. But I do understand why they must first check to see if that is even necessary. Just hope that at some point, if the systemic response is not dramatic, that they do follow through with further injections. Even if that had to be at a low dose.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
